NovelStem International Corp.
NovelStem International Corp. (NSTM) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for NovelStem International Corp. (NSTM), covering cash flow, earnings, and balance sheets.
NovelStem International Corp. (NSTM) Income Statement & Financial Overview
Explore comprehensive income reports for NovelStem International Corp. NSTM, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3000.00 | $3000.00 | $3000.00 | $3000.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $3000.00 | $3000.00 | $3000.00 | $3000.00 |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | -$12940.00 | $566551.00 | $144030.00 | $183306.00 |
| Operating Expenses | $46035.00 | $566551.00 | $144030.00 | $183306.00 |
| Total Costs & Expenses | $46035.00 | $566551.00 | $144030.00 | $183306.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $118675.00 | $105336.00 | $106642.00 | $94764.00 |
| Depreciation & Amortization | -$55975.00 | $0.00 | $0.00 | $180306.00 |
| EBITDA | -$1.73M | -$678551.00 | -$141030.00 | $0.00 |
| EBITDA Ratio | -$575.89 | -$226.18 | -$47.01 | $0.00 |
| Operating Income | -$43035.00 | -$563551.00 | -$141030.00 | -$183310.00 |
| Operating Income Ratio | -$14.35 | -$187.85 | -$47.01 | -$61.10 |
| Other Income/Expenses (Net) | -$1.75M | -$220336.00 | -$106642.00 | -$69764.00 |
| Income Before Tax | -$1.79M | -$783887.00 | -$247672.00 | -$250070.00 |
| Income Before Tax Ratio | -$596.79 | -$261.30 | -$82.56 | -$83.36 |
| Income Tax Expense | $1305.00 | $1.68M | $54953.00 | $53210.00 |
| Net Income | -$1.79M | -$835465.00 | -$302625.00 | -$303280.00 |
| Net Income Ratio | -$597.22 | -$278.49 | -$100.88 | -$101.09 |
| EPS | -$0.04 | -$0.05 | -$0.006 | -$0.006 |
| Diluted EPS | -$0.04 | -$0.05 | -$0.006 | -$0.006 |
| Weighted Avg Shares Outstanding | $46.88M | $46.88M | $46.88M | $46.88M |
| Weighted Avg Shares Outstanding (Diluted) | $46.88M | $46.88M | $46.88M | $46.88M |
Over the last four quarters, NovelStem International Corp. achieved steady financial progress, growing revenue from $3000.00 in Q1 2024 to $3000.00 in Q4 2024. Gross profit stayed firm with margins at 100% in Q4 2024 versus 100% in Q1 2024. Operating income totaled -$43035.00 in Q4 2024, maintaining a -1435% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$1.73M. Net income dropped to -$1.79M, with EPS at -$0.04. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan